TY - JOUR
T1 - Community-acquired Acinetobacter baumannii
T2 - clinical characteristics, epidemiology and pathogenesis
AU - Dexter, Carina
AU - Murray, Gerald L.
AU - Paulsen, Ian T.
AU - Peleg, Anton Y.
PY - 2015/5/1
Y1 - 2015/5/1
N2 - Community-acquired Acinetobacter baumannii (CA-Ab) is a rare but serious cause of community-acquired pneumonia in tropical regions of the world. CA-Ab infections predominantly affect individuals with risk factors, which include excess alcohol consumption, diabetes mellitus, smoking and chronic lung disease. CA-Ab pneumonia presents as a surprisingly fulminant course and is characterized by a rapid onset of fever, severe respiratory symptoms and multi-organ dysfunction, with a mortality rate reported as high as 64%. It is unclear whether the distinct clinical syndrome caused by CA-Ab is because of host predisposing factors or unique bacterial characteristics, or a combination of both. Deepening our understanding of the drivers of overwhelming CA-Ab infection will provide important insights into preventative and therapeutic strategies.
AB - Community-acquired Acinetobacter baumannii (CA-Ab) is a rare but serious cause of community-acquired pneumonia in tropical regions of the world. CA-Ab infections predominantly affect individuals with risk factors, which include excess alcohol consumption, diabetes mellitus, smoking and chronic lung disease. CA-Ab pneumonia presents as a surprisingly fulminant course and is characterized by a rapid onset of fever, severe respiratory symptoms and multi-organ dysfunction, with a mortality rate reported as high as 64%. It is unclear whether the distinct clinical syndrome caused by CA-Ab is because of host predisposing factors or unique bacterial characteristics, or a combination of both. Deepening our understanding of the drivers of overwhelming CA-Ab infection will provide important insights into preventative and therapeutic strategies.
UR - http://www.scopus.com/inward/record.url?scp=84927618494&partnerID=8YFLogxK
U2 - 10.1586/14787210.2015.1025055
DO - 10.1586/14787210.2015.1025055
M3 - Review article
C2 - 25850806
AN - SCOPUS:84927618494
VL - 13
SP - 567
EP - 573
JO - Expert Review of Anti-Infective Therapy
JF - Expert Review of Anti-Infective Therapy
SN - 1478-7210
IS - 5
ER -